regulatory
confidence high
sentiment negative
materiality 0.80
Quince Therapeutics, Inc. (QNCX): Nasdaq/NYSE listing notice — Quince Therapeutics receives Nasdaq bid price deficiency notice; 180-day cure period.
Quince Therapeutics, Inc.
- Notice on Dec 13, 2022: closing bid price below $1.00 for 30 consecutive days.
- Initial compliance period until June 12, 2023 to regain bid price ≥$1.00 for 10 days.
- If not compliant by June 12, may transfer to Nasdaq Capital Market for second 180-day period.
- Failure to cure could result in delisting from Nasdaq Global Select Market.